Institution statistics

FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III - Spain 

Ranking results:

Past rankings:
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:100-200
Total Number of Projects:400-500
Networking Rank (Reputation):600-700
Partner Constancy:800-900
Project Leadership Index:600-700
2012
Criterium:Position:
Overall Score:600-700
Total Project Funding:500-600
Total Project Funding per Partner:600-700
Total Number of Projects:67
Networking Rank (Reputation):700-800
Networking Rank (Reputation):700-800
Partner Constancy:46
Project Leadership Index:75
Diversity Index:37
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding:700-800
Total Project Funding per Partner:200-300
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:200-300
Total Project Funding:200-300
Total Project Funding per Partner:48
Total Number of Projects:200-300
Networking Rank (Reputation):300-400
Partner Constancy:> 1000
Project Leadership Index:60
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:600-700
Total Project Funding:300-400
Total Project Funding per Partner:100-200
Total Number of Projects:200-300
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:600-700
2007
Criterium:Position:
Overall Score:900-1000
Total Project Funding:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):400-500
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2018-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 86
As coordinator: 2
As participant: 68
Sole participant: 16
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2018 2.499.875 0 2.499.875 1
2017 170.122 0 170.122 1
2016 0 8.960.273 2.493.201 2
2015 2.488.850 36.753.230 5.254.655 1 5
2014 100.000 1.997.819 2.097.819 1 1
2013 100.000 14.622.363 1.799.046 1 3
2012 226.548 22.486.405 1.608.397 1 3
2011 3.458.206 66.785.072 4.011.650 4 7
2010 161.900 24.693.589 4.018.073 1 3
2009 237.283 43.675.698 11.019.738 1 9
2008 0 31.247.290 4.469.434 10
2007 110.000 25.207.190 1.410.518 2 3
2006 160.000 41.908.096 3.367.729 2 9
2005 1.269.368 25.570.715 2.615.205 2 4
2004 0 38.783.750 1.976.863 6
2001 0 3.298.281 494.946 2
2000 0 2.512.247 228.386 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
EUROPEAN MOLECULAR BIOLOGY LABORATORY14
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE14
UNIVERSITY COLLEGE LONDON10
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS9
KAROLINSKA INSTITUTE9
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE8
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM8
ISTITUTO EUROPEO DI ONCOLOGIA8
MEDICAL RESEARCH COUNCIL8
GENOME RESEARCH7
COMMISSARIAT A L'ENERGIE ATOMIQUE6
DEUTSCHES KREBSFORSCHUNGSZENTRUM6
INSTITUT CURIE6
STICHTING KATHOLIEKE UNIVERSITEIT6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
THE HEBREW UNIVERSITY OF JERUSALEM6
UNIVERSITAET ULM6
WEIZMANN INSTITUTE OF SCIENCE6
CENTRE DE REGULACIO GENOMICA5
DANISH CANCER SOCIETY5
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH5
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT5
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE5
INSTITUT GUSTAVE ROUSSY5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
INSTITUT PASTEUR5
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV5
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON5
THE UNIVERSITY OF EDINBURGH5
UNIVERSITE LIBRE DE BRUXELLES5
UNIVERSITY OF COPENHAGEN5
UNIVERSITY OF HELSINKI5
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS4
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE4
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG4
INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE4
LEIDEN UNIVERSITY MEDICAL CENTER4
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN4
NATIONAL HELLENIC RESEARCH FOUNDATION4
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH4
SWISS INSTITUTE OF BIOINFORMATICS4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITAET ZU KOELN4
UNIVERSITE DE GENEVE4
UNIVERSITY OF AARHUS4
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS3
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION3
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING3
CENTRE FOR RESEARCH AND TECHNOLOGY HELLAS3
CONSIGLIO NAZIONALE DELLE RICERCHE3
DANMARKS TEKNISKE UNIVERSITET3
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR3
FONDAZIONE TELETHON3
FUNDACIO PRIVADA PARC CIENTIFIC DE BARCELONA3
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE3
KATHOLIEKE UNIVERSITEIT LEUVEN3
LUNDS UNIVERSITET3
MARTIN LUTHER UNIVERSITAET HALLE WITTENBERG3
PHILIPPS UNIVERSITAET MARBURG3
SECONDA UNIVERSITA DEGLI STUDI DI NAPOLI3
TECHNICAL UNIVERSITY OF DENMARK3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA3
UNIVERSITA DEGLI STUDI DI TORINO3
UNIVERSITAET BERN3
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI3
UNIVERSITY OF BIRMINGHAM3
UNIVERSITY OF BOLOGNA3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF GLASGOW3
UNIVERSITY OF NEWCASTLE UPON TYNE3
AARHUS UNIVERSITETSHOSPITAL SKEJBY2
ACADEMISCH ZIEKENHUIS GRONINGEN2
ACADEMISCH ZIEKENHUIS LEIDEN2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNASKAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS2
BRUNEL UNIVERSITY2
CAMBRIDGE CELL NETWORKS2
CANCER RESEARCH UK2
CELLZOME2
CEMM FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN2
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE2
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL2
CONCENTRIS RESEARCH MANAGEMENT2
CSCTIETEEN TIETOTEKNIIKAN KESKUS OY2
DIAGENODE2
DIAGNOSWISS2
ECANCERMEDICALSCIENCE2
ECOLE NORMALE SUPERIEURE DE LYON2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
EUROPEAN CANCER ORGANISATION2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
FORSCHUNGSINSTITUT FUER MOLEKULARE PATHOLOGIE GESMBH2
FUNDACAO CALOUSTE GULBENKIAN2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
FUNDACION IMDEA NANOCIENCIA2
GENEART2
GROUPEMENT EUROPEEN D INTERET ECONOMIQUE ORGANISATION OF EUROPEAN CANCER INSTITUTES OECI2
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE2
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL2
Constancy:

Total number of partners:838

Partner loyalty:
Frequent Partner: (> 2 projects): 343
Rare Partner: 495

Frequent / Rare Partner Ratio: 0.69

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES53
RTD HORIZONTAL TOPICS30
SOCIAL AND ECONOMIC CONCERNS21
INDUSTRY AND TECHNOLOGY4
PROTECTING MAN AND HIS ENVIRON2
ENERGY1
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2018-01-01Chronic Systemic Inflammation: Functional organ cross-talk in inflammatory disease and cancer CSI-Funcoordinator2.499.8751
2017-04-01Long range-acting drivers of premetastatic niches in melanoma METMELcoordinator170.1221
2016-04-01Nanomedicine upscaling for early clinical phases of multimodal cancer therapy NoCanTherparticipant7.113.77911
2016-01-01The Physiology of Nutrient Sensing by mTOR NutrientSensingVivoparticipant1.846.4941
2015-12-01Training Network for the Immunotherapy of Cancer IMMUTRAINparticipant3.627.5259
2015-10-01Integrating Genomics and Avatar Mouse Models to Personalize Pancreatic Cancer Treatment AVATARparticipant2.498.6882
2015-10-01New Frontiers in Cellular Reprogramming: Exploiting Cellular Plasticity CELLPLASTICITYcoordinator2.488.8501
2015-09-01Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES) BRIDGESparticipant6.200.00018
2015-09-01ELIXIR-EXCELERATE: Fast-track ELIXIR implementation and drive early user exploitation across the life-sciences. ELIXIR-EXCELERATEparticipant19.051.48244
2015-06-01Open Mining INfrastructure for TExt and Data OpenMinTeDparticipant5.375.53616
2014-07-01DNA Damage Response (DDR) signaling in tumor formation and therapeutic resistance of gliomas GLIDDcoordinator100.0001
2014-03-01Investigating the causes and consequences of replication stress in mammalian health RSHEALTHparticipant1.997.8191
2013-11-01Integrative Analysis of Gene Functions in Cellular and Animal Models of Pancreatic Cancer CAM-PACparticipant11.193.10814
2013-09-01Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction TRANSBIOBCparticipant3.260.3594
2013-07-01Bioinformatics and Integrative Genomics for a Novel Personalized Cancer Therapy PERSMEDOMICScoordinator100.0001
2013-03-01Improving the selectivity of kinase inhibitors: Characterizing binding mechanisms of inhibitors targeting inactive states and allosteric sites KIBINDINGparticipant168.8962
2012-11-01"RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research" RD-CONNECTparticipant11.997.11127
2012-11-01"Risk, Stem Cells and Tissue Kinetics – Ionising Radiation" RISK - IRparticipant6.685.00012
2012-10-01Joint training and research network on Chromatin Dynamics and the DNA Damage Response ADDRESSparticipant3.804.29410
2012-09-01Role of the protein kinase Mastl in Cell Division and Cancer Mastl CDCcoordinator226.5481
2011-10-01Clonal analysis in pancreatic development, differentiation and carcinogenesis PanCloncoordinator230.9801
2011-10-01A BLUEPRINT of Haematopoietic Epigenomes BLUEPRINTparticipant29.996.66445
2011-07-01Rational designing of new meganucleases as molecular scissors for genomic tailoring SMARTBREAKERcoordinator75.0001
2011-06-13Multifunctional Nanotechnology for selective detection and Treatment of cancer MULTIFUNparticipant9.799.99417
2011-04-01Safer gene repair and targeting based on the monomeric meganuclease I-DmoI by design of homologous-recombination-inducing nickase activity DmoNickaseDesigncoordinator155.4171
2011-04-01Development of novel diagnostic and therapeutic approaches to improve patient outcome in lung and pancreatic tumours CANCERALIAcoordinator2.996.8097
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-01-01A European Platform for Translational Cancer Research EUROCANPLATFORMparticipant11.998.45428
2011-01-01European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults ENS@T-CANCERparticipant5.993.97816
2011-01-01New approaches for the targeted therapy of Non-Small Cell Lung Cancer LUNGTARGETparticipant2.997.33210
2011-01-01Identifying biomarkers of ageing using whole transcriptomic sequencing EuroBATSparticipant2.998.6505
2010-11-01ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours ASSETparticipant11.999.15619
2010-06-01Systems Biology of Mitosis MitoSysparticipant10.198.24114
2010-04-01Ras Genes in Health and Disease RAS AHEADparticipant2.496.1921
2010-03-01The role of activation-induced cytidine deaminase in inflammation-induced carcinogenesis InflAIDCancoordinator161.9001
2009-12-01Role of histone modifications in dna damage response in mammals HISTONEDDRcoordinator237.2831
2009-12-01The Microme project: A knowledge-based bioinformatics framework for microbial pathway genomics MICROMEparticipant5.263.15016
2009-11-01AP-1 (Fos/Jun) Functions in Physiology and Disease AP-1-FUNparticipant2.500.0001
2009-11-01Nucleosome structure & function across biological scales and biological function NUCLEOSOME4Dparticipant4.609.51117
2009-07-01Molecular characterization and targeted elimination of metastatic pancreatic cancer stem cells PA-CSCparticipant2.335.1051
2009-05-01FROM TELOMERE CHROMATIN TO STEM CELL BIOLOGY TEL STEM CELLparticipant2.000.0001
2009-05-01Establishing an efficient network for cancer communication in Europe EUROCANCERCOMSparticipant1.252.54218
2009-05-01Collaborative oncological gene-environment study COGSparticipant11.715.50116
2009-04-01COMMOM MECHANISMS UNDERLYING CANCER AND AGEING CANCER&AGEINGparticipant2.000.0001
2009-01-01Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies INFLA-CAREparticipant11.999.88922
2008-12-01Molecular mechanisms of mature B cell lymphomagenesis BCLYMparticipant1.596.0002
2008-12-01Genome maintenance in the context of chromatin CHROMOREPAIRparticipant948.4261
2008-09-01Genetic and genomic study of cell competition in Drosophila SUPERCOMPETITORSparticipant970.1002
2008-07-01Targeting environmental pollution with engineered microbial systems a la carte TARPOLparticipant997.21518
2008-04-01European Study to Establish Biomarkers of Human Ageing MARK-AGEparticipant11.989.32728

overview shows latest 50 from 86 projects (2000-01-01 - 2018-12-31)
A full list of projects can be found here:

Alias institution names:
  • FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLA?GICAS CARLOS III
  • FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS
  • FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum
Ads: